UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): January 13, 2016

                               CEL-SCI CORPORATION
                       ----------------------------------
             (Exact name of registrant as specified in its charter)


          Colorado                      001-11889                84-0916344
  -----------------------          ------------------         ----------------
(State or other jurisdiction      (Commission File No.)     (IRS  Employer
    of incorporation)                                        Identification No.)

                              8229 Boone Blvd. #802
                                Vienna, VA 22182
                 -----------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (703) 506-9460


                                       N/A
                 -----------------------------------------------
          (Former name or former address if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:

[ ] Written  communications  pursuant  to Rule 425  under the  Securities  Act
    (17CFR 230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12  under the  Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
    Exchange Act (17 CFR 240.14d-2(b)

[ ] Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
    Exchange Act (17 CFR 240.13e-14c))

<PAGE>

Item 1.02   Termination of a Material Definitive Agreement.

     As of January 12, 2016 the  Company  owed the de Clara Trust (the  "Trust")
$1,105,989, which amount included accrued and unpaid interest. The maturity date
of the loan from the Trust  was July 6,  2018.  Although  the Trust  could  only
demand  payment prior to July 6, 2018 upon giving the Company a minimum  ten-day
notice,  on  January  13,  2016 the  Company  and the  Trust  agreed to the full
repayment of the loan.  Following  repayment,  the Trust invested  $1,110,000 in
shares  of the  Company's  common  stock  and  warrants.  The de Clara  Trust is
controlled  by Geert  Kersten,  the  Company's  Chief  Executive  Officer  and a
Director.







                                       2
<PAGE>



                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  January 15, 2016             CEL-SCI CORPORATION



                                    By:/s/ Patricia B. Prichep
                                       -----------------------------------
                                       Patricia B. Prichep,
                                       Senior Vice President of Operations
[{"type": "8-K", "sequence": "1", "filename": "form8kitem102prepay1-16.txt", "description": "FORM 8-K ITEM 1.02", "secsgml_size_bytes": 3384}]
{"company-data": {"conformed-name": "CEL SCI CORP", "cik": "0000725363", "assigned-sic": "2836", "irs-number": "840916344", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11889", "film-number": "161346003"}, "business-address": {"street1": "8229 BOONE BLVD .", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7035069460"}, "mail-address": {"street1": "8229 BOONE BLVD.", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182"}, "former-company": {"former-conformed-name": "INTERLEUKIN 2 INC", "date-changed": "19880317"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): January 13, 2016

                               CEL-SCI CORPORATION
                       ----------------------------------
             (Exact name of registrant as specified in its charter)

          Colorado                      001-11889                84-0916344
  -----------------------          ------------------         ----------------
(State or other jurisdiction      (Commission File No.)     (IRS  Employer
    of incorporation)                                        Identification No.)

                              8229 Boone Blvd. #802
                                Vienna, VA 22182
                 -----------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (703) 506-9460

                                       N/A
                 -----------------------------------------------
          (Former name or former address if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:

[ ] Written  communications  pursuant  to Rule 425  under the  Securities  Act
    (17CFR 230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12  under the  Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
    Exchange Act (17 CFR 240.14d-2(b)

[ ] Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
    Exchange Act (17 CFR 240.13e-14c))
Item 1.02   Termination of a Material Definitive Agreement.

     As of January 12, 2016 the  Company  owed the de Clara Trust (the  "Trust")
$1,105,989, which amount included accrued and unpaid interest. The maturity date
of the loan from the Trust  was July 6,  2018.  Although  the Trust  could  only
demand  payment prior to July 6, 2018 upon giving the Company a minimum  ten-day
notice,  on  January  13,  2016 the  Company  and the  Trust  agreed to the full
repayment of the loan.  Following  repayment,  the Trust invested  $1,110,000 in
shares  of the  Company's  common  stock  and  warrants.  The de Clara  Trust is
controlled  by Geert  Kersten,  the  Company's  Chief  Executive  Officer  and a
Director.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date:  January 15, 2016             CEL-SCI CORPORATION

                                    By:/s/ Patricia B. Prichep
                                       -----------------------------------
                                       Patricia B. Prichep,
                                       Senior Vice President of Operations